Red Whale Primary Care Pod

Alopecia: when to reassure, when a prompt referral to secondary care is needed, and everything in between...

Red Whale Season 2 Episode 14

Send us a text

Grab your trainers, your dog lead or a pumpkin spice latte and join us for some free CPD as we have another relaxed round up of recent Red Whale primary care Pearls of wisdom.  September was another bumper month of information, meaning that we can’t possibly squeeze it all into one handy sized episode, so in the first of two episodes this month, Ali and Nik discuss: 

  • How to approach alopecia consultations. Having a framework for conditions that patients have to pluck up courage to ask about can be really helpful…
  •  Workplace-based assessment (WPBA) demystified. We’re here to support the next generation of GP trainees, along with their supervisors. 

Listen as soon as you can to ensure you have full access to all the free resources. 

The rest of the Pearls from September will be covered next week along with a new best intentions story to put a smile on your face.

Alopecia UK

British Association of Dermatologists - alopecia areata

British Association of Dermatologists - female pattern hair loss

British Association of Dermatologists - male pattern hair loss


The official MRCGP website which can be found here

CEPS 

Send us your feedback podcast@redwhale.co.uk or send a voice message

Sign up to receive Pearls here. Pearls are available for 3 months from publish date. After this, you can get access them plus 100s more articles when you buy a one-day online course from Red Whale OR sign up to Red Whale Unlimited. Find out more here.

Follow us: X, Facebook, Instagram, LinkedIn

Disclaimer: We make every effort to ensure the information in this podcast is accurate and correct at the date of publication, but it is of necessity of a brief and general nature, and this should not replace your own good clinical judgement, or be regarded as a substitute for taking professional advice in appropriate circumstances. In particular, check drug doses, side-effects and interactions with the British National Formulary. Save insofar as any such liability cannot be excluded at law, we do not accept any liability for loss of any type caused by reliance on the information in this podcast.

...